$130.00
– Vendido| /
Matrix Labs Mass LGD is a multi-compound formulation containing three investigational Selective Androgen Receptor Modulators (SARMs): LGD-4033, LGD-3303, and LGD-2226.
Each capsule contains a combined 23mg of listed active compounds, bringing together three distinct androgen receptor modulators that have attracted scientific interest for their potential effects on androgen signaling, skeletal muscle physiology, and other biological pathways.
Unlike single-compound LGD formulations, Matrix Labs Mass LGD combines three separate research substances in one capsule. However, the effects, interactions, and safety of this specific combination have not been established in controlled human clinical trials.
Androgen Receptor Modulation
LGD compounds belong to a class of investigational substances studied for their interactions with androgen receptors and related biological pathways.
Skeletal Muscle Physiology
Certain SARMs have been investigated for their potential effects on lean body mass, muscle tissue, and androgen-mediated processes.
Bone Metabolism Research
Androgen receptor signaling plays a role in skeletal physiology, making selective androgen receptor modulators an area of scientific interest.
Endocrine Signaling
Research involving SARMs includes investigation of hormonal biomarkers, endocrine feedback mechanisms, and potential suppression of natural hormone production.
Multi-Compound Research
Mass LGD combines three distinct LGD compounds, although no synergistic effect or improved safety profile has been established for this formulation.
LGD-4033 (Ligandrol) – 3mg
An investigational nonsteroidal SARM that has been evaluated in early human clinical research involving lean body mass and hormonal biomarkers.
LGD-3303 – 10mg
An investigational SARM studied primarily in preclinical research involving androgen receptor activity and tissue-selective effects.
LGD-2226 – 10mg
An investigational androgen receptor modulator examined in preclinical research for its potential effects on muscle and bone-related biological pathways.
Brand: Matrix Labs
Product: Mass LGD
Category: Investigational SARM Research Compounds
Form: Capsules
Quantity: 60 Capsules
Total Listed Active Compounds: 23mg per capsule
FOR RESEARCH PURPOSES ONLY — NOT FOR HUMAN CONSUMPTION.
Matrix Labs Mass LGD contains investigational selective androgen receptor modulators that are not approved by the U.S. Food and Drug Administration (FDA) for human use.
The safety, effectiveness, pharmacological interactions, and long-term effects of this three-compound formulation have not been established.
This product is not intended for use as a dietary supplement, medication, bodybuilding supplement, or athletic performance enhancer.
No human consumption or dosing recommendations are provided.
